Qsc Peptides Ly3437943 Research Peptide 5mg 10mg 15mg GLP-1r Qsc Retatrutide Qsc Semaglutide Qsc Tirzepatide

Min.Order: 1
Product origin: Qingdao, Shandong, China
Infringement complaint: complaintComplaint
US$ 38 ~ 48


Products Name: Retatrutide
Trade Name: LY-3437943
CAS No.:2381089-83-2
Molecular Formula: C221H342N46O68
Molecular Weight: 4731.33g/mol
Appearance: White Lyophilized powder
Reconstitution: Required 
Storage: After reconstitution store at 2°C - 8°C

What is Retatrutide?

Retatrutide, also known as LY-3437943, is a novel medication developed by the pharmaceutical company Eli Lilly with significant potential for the treatment of obesity and diabetes. This injectable drug, soon to be approved by the FDA, is classified as a GGG tri-agonist, GLP-1/GIP/glucagon tri-agonist. It shares similarities with existing weight-loss medications like tirzepatide and semaglutide but offers enhanced efficacy. When used in conjunction with a proper diet, regular exercise, and lifestyle modifications, Retatrutide can help improve weight loss outcomes and address obesity-related comorbidities such as diabetes and hypertension.

Retatrutide surpasses other weight-loss medications in terms of effectiveness. It exerts its therapeutic effects through three crucial mechanisms:

Gastric inhibitory polypeptide receptor (GIPR) agonist: Acting as a GIP receptor agonist, Retatrutide enhances appetite suppression and prevents fat accumulation, leading to reduced energy intake and increased energy expenditure.

Glucagon-like peptide-1 receptor (GLP-1R) agonist: By improving insulin release from the pancreas and reducing the release of glucagon (a hormone that elevates blood sugar levels), Retatrutide aids in weight reduction and enhances blood glucose control.

Glucagon receptor (GR) agonist: Retatrutide improves blood sugar levels by reducing the release of glucagon. It also decreases food intake and increases energy expenditure, resulting in weight loss.

Benefits of GLP-1 agonists:

Slows down the emptying of food from the stomach

Prevents excessive sugar production by the liver

Stimulates increased insulin production by the pancreas in response to high blood sugar levels

Helps regulate blood glucose levels

Reduces post-meal hyperglycemia

Lowers fasting insulin and fasting glucose levels

Decreases hemoglobin A1c levels

Suppresses appetite, reduces calorie intake, and inhibits weight gain

Lowers triglyceride levels and oxidative stress associated with high LDL cholesterol

Induces weight loss, particularly at higher doses in obese patients

Decreases leptin levels and increases leptin sensitivity

Promotes the conversion of white fat to brown fat 

Our Main Products:

retatrutide 2381089-83-2
semaglutide 910463-68-2
Tirzepatide 2023788-19-2
GHK-Cu (Copper Peptide) 49557-75-7


Product Tag:
Related categories:
Scroll to Top